Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 206 Show results per page	View Search Criteria \| Help With Results


1.		A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Closed				18 and over				Pharmaceutical / Industry				ML18491 NCT00118755

Last Modified: 3/1/1998


2.		Phase II/III Randomized Study of Fluorouracil/Leucovorin with vs without Oxaliplatin for Inoperable Metastatic Colorectal Cancer (Summary Last Modified 03/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 to 75								FRE-DEB95-OXA-01 EU-96023


3.		Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Oesophageal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				L-9326 NCT00160030

Last Modified: 7/10/2007 First Published: 12/22/2005


4.		Phase II/III Randomized Study of Oxaliplatin, Leucovorin Calcium, and Fluorouracil With Versus Without Maintenance Leucovorin Calcium and Fluorouracil in Patients With Inoperable Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 to 80				Other, Pharmaceutical / Industry				GERCOR-OPTIMOX2 GERCOR-OPTIMOX2-2003, GERCOR-OPTIMOX2-C02-2, EU-20566, SANOFI-GERCOR-OPTIMOX2, NCT00274872

Last Modified: 5/17/2007 First Published: 5/1/1998


5.		Phase III Randomized Study of Leucovorin Calcium Plus Fluorouracil With Either Irinotecan or Oxaliplatin in Patients With Recurrent Metastatic Colorectal Cancer (Summary Last Modified 05/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 75				Pharmaceutical / Industry				FRE-GERCOR-C97-3/CPTF308 FRE-C97-3/CPTF301, FRE-C97-3/CPTF308, RP-FRE-C97-3/CPTF308, EU-97044, NCT00003260

Last Modified: 4/24/2008 First Published: 8/1/1998


6.		Phase III Randomized Study of Chronomodulated Versus Nonchronomodulated Administration of Fluorouracil, Leucovorin Calcium, and Oxaliplatin as First Line Treatment in Patients With Locoregionally Recurrent or Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18-75								EORTC-05963 NCT00003287

Last Modified: 6/18/2008 First Published: 11/1/1998


7.		Phase III Randomized Study of Combinations of Oxaliplatin, Fluorouracil, Leucovorin Calcium, and Irinotecan as Initial Therapy in Patients With Advanced Adenocarcinoma of the Colon and Rectum

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				NCCTG-N9741 CAN-NCIC-CO13, CLB-89804, E-N9741, SWOG-N9741, N9741, NCT00003594, CO13

Last Modified: 6/20/2008 First Published: 3/1/2000


8.		Phase III Study of Fluorouracil and Leucovorin Calcium With or Without Oxaliplatin in Patients With Stage II or III Carcinoma of the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Any age				NCI				NSABP-C-07 NCT00004931, NSABP-C-07

Last Modified: 6/18/2008 First Published: 4/1/2000


9.		Phase III Randomized Study of Irinotecan Versus Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Patients With Advanced Colorectal Cancer Previously Treated With Fluorouracil

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				NCCTG-N9841 ECOG-N9841, SWOG-N9841, NCT00005036, N9841

Last Modified: 7/2/2003 First Published: 11/1/2000


10.		Phase III Randomized Study of Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 80				Other				FRE-GERCOR-OPTIMOX-2000 EU-20034, NCT00006468

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute